NCT02915211 - Evaluation of Keyo in Children With Epilepsy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Intractable EpilepsyGlucose Transporter Type 1 Deficiency SyndromeKetogenic Dieting

Interventions

DIETARY_SUPPLEMENT

Keyo

Keyo is a Food for Special Medical Purposes (FSMP) and is intended for use in the KD. It has a fat to protein and carbohydrate ratio of 3 to 1. This makes it appropriate for inclusion in all versions of the KD - classical, MCT, MAD and LGI. Keyo has been designed as a nutritionally complete, ready to use, pleasant tasting and versatile medical food for use in a KD.

Trial Locations (2)

M13 9WL

Central Manchester University Hospitals NHS Foundation Trust, Manchester

LS1 3EX

Leeds Teaching Hospitals NHS Trust, Leeds

All Listed Sponsors

lead

Vitaflo International, Ltd

INDUSTRY